Clinical Trials
2 trialsNCT04477512 2025-11-12
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Washington University School of Medicine
Phase 1 Completed
NCT00766324 2014-05-28
PHA-739358 for Treatment of Hormone Refractory Prostate Cancer
Nerviano Medical Sciences
Phase 2 Completed